The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Celiac Disease market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Celiac Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Celiac Disease is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Celiac Disease in Hospital is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Celiac Disease include Roche, Merck, Johnson & Johnson, BiolineRx, Pfizer, Innovate Biopharmaceuticals, ImmusanT, Novartis and Bristol-Myers Squibb, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Celiac Disease, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Celiac Disease.
Report Scope
The Celiac Disease market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Celiac Disease market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Celiac Disease companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
- Roche
- Merck
- Johnson & Johnson
- BiolineRx
- Pfizer
- Innovate Biopharmaceuticals
- ImmusanT
- Novartis
- Bristol-Myers Squibb
- Immunomedics
Segment by Type
- Distension
- Diarrhea
- Anorexia
- Others
Segment by Application
- Hospital
- Clinic
By Region
- North America (United States, Canada)
- Europe (Germany, France, U.K., Italy, Russia)
- Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
- Latin America (Mexico, Brazil, Argentina)
- Middle East & Africa (Turkey, Saudi Arabia, UAE)
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Celiac Disease companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Celiac Disease Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Distension
1.2.3 Diarrhea
1.2.4 Anorexia
1.2.5 Others
1.3 Market by Application
1.3.1 Global Celiac Disease Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Celiac Disease Market Perspective (2019-2030)
2.2 Celiac Disease Growth Trends by Region
2.2.1 Global Celiac Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Celiac Disease Historic Market Size by Region (2019-2024)
2.2.3 Celiac Disease Forecasted Market Size by Region (2025-2030)
2.3 Celiac Disease Market Dynamics
2.3.1 Celiac Disease Industry Trends
2.3.2 Celiac Disease Market Drivers
2.3.3 Celiac Disease Market Challenges
2.3.4 Celiac Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Celiac Disease Players by Revenue
3.1.1 Global Top Celiac Disease Players by Revenue (2019-2024)
3.1.2 Global Celiac Disease Revenue Market Share by Players (2019-2024)
3.2 Global Celiac Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Celiac Disease Revenue
3.4 Global Celiac Disease Market Concentration Ratio
3.4.1 Global Celiac Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Celiac Disease Revenue in 2023
3.5 Celiac Disease Key Players Head office and Area Served
3.6 Key Players Celiac Disease Product Solution and Service
3.7 Date of Enter into Celiac Disease Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Celiac Disease Breakdown Data by Type
4.1 Global Celiac Disease Historic Market Size by Type (2019-2024)
4.2 Global Celiac Disease Forecasted Market Size by Type (2025-2030)
5 Celiac Disease Breakdown Data by Application
5.1 Global Celiac Disease Historic Market Size by Application (2019-2024)
5.2 Global Celiac Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Celiac Disease Market Size (2019-2030)
6.2 North America Celiac Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Celiac Disease Market Size by Country (2019-2024)
6.4 North America Celiac Disease Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Celiac Disease Market Size (2019-2030)
7.2 Europe Celiac Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Celiac Disease Market Size by Country (2019-2024)
7.4 Europe Celiac Disease Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Celiac Disease Market Size (2019-2030)
8.2 Asia-Pacific Celiac Disease Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Celiac Disease Market Size by Region (2019-2024)
8.4 Asia-Pacific Celiac Disease Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Celiac Disease Market Size (2019-2030)
9.2 Latin America Celiac Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Celiac Disease Market Size by Country (2019-2024)
9.4 Latin America Celiac Disease Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Celiac Disease Market Size (2019-2030)
10.2 Middle East & Africa Celiac Disease Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Celiac Disease Market Size by Country (2019-2024)
10.4 Middle East & Africa Celiac Disease Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Celiac Disease Introduction
11.1.4 Roche Revenue in Celiac Disease Business (2019-2024)
11.1.5 Roche Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Celiac Disease Introduction
11.2.4 Merck Revenue in Celiac Disease Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Detail
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Celiac Disease Introduction
11.3.4 Johnson & Johnson Revenue in Celiac Disease Business (2019-2024)
11.3.5 Johnson & Johnson Recent Development
11.4 BiolineRx
11.4.1 BiolineRx Company Detail
11.4.2 BiolineRx Business Overview
11.4.3 BiolineRx Celiac Disease Introduction
11.4.4 BiolineRx Revenue in Celiac Disease Business (2019-2024)
11.4.5 BiolineRx Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Detail
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Celiac Disease Introduction
11.5.4 Pfizer Revenue in Celiac Disease Business (2019-2024)
11.5.5 Pfizer Recent Development
11.6 Innovate Biopharmaceuticals
11.6.1 Innovate Biopharmaceuticals Company Detail
11.6.2 Innovate Biopharmaceuticals Business Overview
11.6.3 Innovate Biopharmaceuticals Celiac Disease Introduction
11.6.4 Innovate Biopharmaceuticals Revenue in Celiac Disease Business (2019-2024)
11.6.5 Innovate Biopharmaceuticals Recent Development
11.7 ImmusanT
11.7.1 ImmusanT Company Detail
11.7.2 ImmusanT Business Overview
11.7.3 ImmusanT Celiac Disease Introduction
11.7.4 ImmusanT Revenue in Celiac Disease Business (2019-2024)
11.7.5 ImmusanT Recent Development
11.8 Novartis
11.8.1 Novartis Company Detail
11.8.2 Novartis Business Overview
11.8.3 Novartis Celiac Disease Introduction
11.8.4 Novartis Revenue in Celiac Disease Business (2019-2024)
11.8.5 Novartis Recent Development
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Detail
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Celiac Disease Introduction
11.9.4 Bristol-Myers Squibb Revenue in Celiac Disease Business (2019-2024)
11.9.5 Bristol-Myers Squibb Recent Development
11.10 Immunomedics
11.10.1 Immunomedics Company Detail
11.10.2 Immunomedics Business Overview
11.10.3 Immunomedics Celiac Disease Introduction
11.10.4 Immunomedics Revenue in Celiac Disease Business (2019-2024)
11.10.5 Immunomedics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
